Innate Pharma SA
Change company Symbol lookup
Select an option...
IPHYF Innate Pharma SA
ROKU Roku Inc
HBAN Huntington Bancshares Inc
AICAF Air China Ltd
BTZ BlackRock Credit Allocation Income Trust
SLG SL Green Realty Corp
SKT Tanger Factory Outlet Centers Inc
SJR Shaw Communications Inc
SJM J M Smucker Co
SJI South Jersey Industries Inc
Go


Based in France
Company profile

Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The Company works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.

Closing Price
$4.72
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.72
Day's Low
4.72
Volume
(Heavy Day)
Volume:
200

10-day average volume:
200
200

LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

1:07 pm ET November 21, 2020 (PR Newswire) Print

Johnson Fistel, LLP, announces that class action lawsuits have commenced on behalf of shareholders of the publicly-traded companies listed below. The Private Securities Litigation Reform Act of 1995 permits any investor who purchased common stock during the Class Period to seek appointment as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. If you wish to serve as lead plaintiff, you must move the Court no later than the dates listed below. If you want to discuss this action or have any questions concerning this notice, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

Additionally, you can Click Here or any of the links below. There is no cost or obligation to you.

Company Name                                Stock Ticker        Join       Class Period Start Class Period End Lead Plaintiff Deadline
Mesoblast Limited                           (NASDAQ: MESO)      Click Here 16/04/2019         01/10/2020       07/12/2020
Royal Caribbean Cruises, Ltd.               (NYSE: RCL)         Click Here 04/02/2020         17/03/2020       07/12/2020
Loop Industries, Inc.                       (NASDAQ: LOOP)      Click Here 24/09/2018         12/10/2020       14/12/2020
Evolus, Inc.                                (NASDAQ: EOLS)      Click Here 01/02/2019         06/07/2020       15/12/2020
Innate Pharma SA                            (NASDAQ: IPHA)      Click Here 10/03/2020         18/09/2020       22/12/2020
First American Financial Corporation        (NYSE: FAF)         Click Here 17/02/2017         22/10/2020       24/12/2020
Zosano Pharma Corporation                   (NASDAQ: ZSAN)      Click Here 13/02/2017         30/09/2020       28/12/2020
Bayerische Motoren Werke Aktiengesellschaft (OTC: BMWYY, BAMXF) Click Here 03/11/2020         24/09/2020       28/12/2020
Neovasc, Inc.                               (NASDAQ: NVCN)      Click Here 01/11/2019         27/10/2020       05/01/2021
Interface, Inc.                             (NASDAQ: TILE)      Click Here 02/03/2018         28/09/2020       11/01/2021

About Johnson Fistel, LLP:Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:Johnson Fistel, LLPJim Baker, 619-814-4471jimb@johnsonfistel.com

https://c212.net/c/img/favicon.png?sn=PH00202&sd=2020-11-21

View original content:http://www.prnewswire.com/news-releases/lead-plaintiff-deadline-johnson-fistel-llp-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-301178437.html

SOURCE Johnson Fistel, LLP

https://rt.prnewswire.com/rt.gif?NewsItemId=PH00202&Transmission_Id=202011211306PR_NEWS_USPR_____PH00202&DateId=20201121

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.